Hua Mao1, Pamela Lockyer1, W H Davin Townley-Tilson1, Liang Xie1, Xinchun Pi2. 1. From the Department of Medicine, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX (H.M., W.H.D.T.-T., L.X., X.P.); and Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill (P.L.). 2. From the Department of Medicine, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX (H.M., W.H.D.T.-T., L.X., X.P.); and Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill (P.L.). xpi@bcm.edu.
Abstract
OBJECTIVE: We recently demonstrated that low-density lipoprotein receptor-related protein 1 (LRP1) is required for cardiovascular development in zebrafish. However, what role LRP1 plays in angiogenesis remains to be determined. To better understand the role of LRP1 in endothelial cell function, we investigated how LRP1 regulates mouse retinal angiogenesis. APPROACH AND RESULTS: Depletion of LRP1 in endothelial cells results in increased retinal neovascularization in a mouse model of oxygen-induced retinopathy. Specifically, retinas in mice lacking endothelial LRP1 have more branching points and angiogenic sprouts at the leading edge of the newly formed vasculature. Increased endothelial proliferation as detected by Ki67 staining was observed in LRP1-deleted retinal endothelium in response to hypoxia. Using an array of biochemical and cell biology approaches, we demonstrate that poly(ADP-ribose) polymerase-1 (PARP-1) directly interacts with LRP1 in human retinal microvascular endothelial cells. This interaction between LRP1 and PARP-1 decreases under hypoxic condition. Moreover, LRP1 knockdown results in increased PARP-1 activity and subsequent phosphorylation of both retinoblastoma protein and cyclin-dependent kinase 2, which function to promote cell cycle progression and angiogenesis. CONCLUSIONS: Together, these data reveal a pivotal role for LRP1 in endothelial cell proliferation and retinal neovascularization induced by hypoxia. In addition, we demonstrate for the first time the interaction between LRP1 and PARP-1 and the LRP1-dependent regulation of PARP-1-signaling pathways. These data bring forth the possibility of novel therapeutic approaches for pathological angiogenesis.
OBJECTIVE: We recently demonstrated that low-density lipoprotein receptor-related protein 1 (LRP1) is required for cardiovascular development in zebrafish. However, what role LRP1 plays in angiogenesis remains to be determined. To better understand the role of LRP1 in endothelial cell function, we investigated how LRP1 regulates mouse retinal angiogenesis. APPROACH AND RESULTS: Depletion of LRP1 in endothelial cells results in increased retinal neovascularization in a mouse model of oxygen-induced retinopathy. Specifically, retinas in mice lacking endothelial LRP1 have more branching points and angiogenic sprouts at the leading edge of the newly formed vasculature. Increased endothelial proliferation as detected by Ki67 staining was observed in LRP1-deleted retinal endothelium in response to hypoxia. Using an array of biochemical and cell biology approaches, we demonstrate that poly(ADP-ribose) polymerase-1 (PARP-1) directly interacts with LRP1 in human retinal microvascular endothelial cells. This interaction between LRP1 and PARP-1 decreases under hypoxic condition. Moreover, LRP1 knockdown results in increased PARP-1 activity and subsequent phosphorylation of both retinoblastoma protein and cyclin-dependent kinase 2, which function to promote cell cycle progression and angiogenesis. CONCLUSIONS: Together, these data reveal a pivotal role for LRP1 in endothelial cell proliferation and retinal neovascularization induced by hypoxia. In addition, we demonstrate for the first time the interaction between LRP1 and PARP-1 and the LRP1-dependent regulation of PARP-1-signaling pathways. These data bring forth the possibility of novel therapeutic approaches for pathological angiogenesis.
Authors: Michael Elser; Lubor Borsig; Paul O Hassa; Suheda Erener; Simon Messner; Taras Valovka; Stephan Keller; Max Gassmann; Michael O Hottiger Journal: Mol Cancer Res Date: 2008-02 Impact factor: 5.852
Authors: Jeffrey M Albert; Carolyn Cao; Kwang Woon Kim; Christopher D Willey; Ling Geng; Dakai Xiao; Hong Wang; Alan Sandler; David H Johnson; Alexander D Colevas; Jennifer Low; Mace L Rothenberg; Bo Lu Journal: Clin Cancer Res Date: 2007-05-15 Impact factor: 12.531
Authors: Philippe Boucher; Wei-Ping Li; Rachel L Matz; Yoshiharu Takayama; Johan Auwerx; Richard G W Anderson; Joachim Herz Journal: PLoS One Date: 2007-05-16 Impact factor: 3.240
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Ahamed Hossain; Lamiya Tauhid; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Syed A Ahmed; Partha S Bhattacharjee Journal: Curr Eye Res Date: 2016-07-21 Impact factor: 2.424
Authors: Dianaly T Au; Allison L Arai; William E Fondrie; Selen C Muratoglu; Dudley K Strickland Journal: Curr Drug Targets Date: 2018 Impact factor: 3.465